Increasing Bone Density by Application of Surface Electrical Stimulation

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02734719

Enrollment

Registered

2016-04-12

Start date

2021-10-01

Completion date

2023-05-30

Last updated

2023-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrical Stimulation, Osteoporosis, Posture

Brief summary

Bonestim system for osteoporosis treatment uses surface electrical stimulation of neuromuscular and skeletal tissue by multipad stimulation electrodes for inducing contractions of the spinal column muscles. The primary aim of this clinical study is to determine if the Bonestim therapy can improve bone density. A secondary aim is to determine whether the applied treatment increases postural stability and facilitation of daily life activities. Inducing of contractions of the spinal column muscles in this manner could be new treatment options for the patients with reduced mobility and the patients with serious contraindications for drugs.

Interventions

DEVICEBonestim

Bonestim is the multipad electrical stimulation device.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* T score at least 1,5 (ideal 2,-2,5) * Stable bone turn over (lab.analyses.)

Exclusion criteria

* fracture,pace maker, malignancy and gastrointestinal problems * chronic corticosteroid therapy * spinal surgery in previous year

Design outcomes

Primary

Measure	Time frame
density of bone measured by central Dxa measurement	6 months

Secondary

Measure	Time frame
sagittal flexibility measured by Schober measurement	6 months
daily activities measured by Oswestry disability index	6 months

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026